Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

687
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
687
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumption of whole and refined grains and the risk of gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project.

European journal of nutrition·2026
Same author

Processed meat intake and gastric adenocarcinoma risk among adults in Central-West Brazil: a case-control study.

BMC nutrition·2026
Same author

Adherence to pro-vegetarian dietary patterns and gastric cancer risk: a pooled analysis of the StoP Consortium.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

Health System Factors in Head and Neck Cancer Diagnosis: A HEADSpAcE Consortium Qualitative Study in Glasgow and Montevideo.

Head & neck·2026
Same author

Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.

International journal of cancer·2026
Same author

Inequalities in time to cancer treatment initiation over a decade in Brazil.

Revista de saude publica·2026

Related Experiment Video

Updated: Mar 14, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842

Cross-cancer survival prediction using machine learning models.

Lucas Buk Cardoso1, Jones Eduardo Egydio2, Tatiana Natasha Toporcov3

  • 1Center for Embeded Eletronic Systems, Instituto Mauá de Tecnologia, São Caetano do Sul, 09580-900, Brazil. lucas.cardoso@maua.br.

Scientific Reports
|March 13, 2026
PubMed
Summary
This summary is machine-generated.

Artificial intelligence models can predict cancer survival across different types. Machine learning shows promise for improving cancer survival predictions, especially for rare cancers with limited data.

Keywords:
CancerCross-predictionMachine learningSurvival predictionXGBoost

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

986
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Related Experiment Videos

Last Updated: Mar 14, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

986
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning

Background:

  • Cancer presents a significant global health challenge, necessitating advanced tools for improved patient outcomes.
  • The increasing volume of healthcare data highlights the need for sophisticated analytical methods like artificial intelligence (AI).
  • AI offers potential for enhancing early cancer detection and optimizing treatment strategies.

Purpose of the Study:

  • To investigate the efficacy of machine learning models in predicting three-year cancer survival across different cancer types.
  • To assess the feasibility of cross-prediction using models trained on one cancer type for others, particularly focusing on frequent and digestive system cancers.
  • To address data scarcity challenges in rare cancer types through cross-predictive modeling.

Main Methods:

  • Utilized machine learning algorithms, specifically XGBoost and LightGBM, for predictive modeling.
  • Extracted and analyzed data from the Hospital Based Cancer Registries of São Paulo (2000-2019).
  • Employed a consistent data selection protocol to enable cross-prediction between various cancer types, including oral cavity, esophageal, and stomach cancers.

Main Results:

  • A machine learning model trained on a combined dataset of oral cavity, esophageal, and stomach cancers achieved a balanced accuracy of 80.18% for predicting three-year survival.
  • The cross-predictive model's performance was comparable to a model trained specifically on stomach cancer data (79.92%), with no significant statistical difference.
  • These findings demonstrate the potential of cross-prediction in enhancing survival prediction accuracy.

Conclusions:

  • Machine learning models trained on specific cancer data can be effectively applied for cross-prediction to estimate survival in other cancer types.
  • Cross-prediction holds significant promise for improving survival predictions in rare cancer types, mitigating challenges associated with limited data.
  • The study underscores the value of AI in healthcare for advancing oncological research and clinical decision-making.